Showing results (391-400 of 992) with videos related to
Sort By:
Pageof 100
Journal of Opioid Management|August 23, 2017
The prevalence of nasal obstruction as a consideration in the treatment of opioid overdoseScott G Weiner, Andrew R Joyce, Heather N ThomsonJournal of Opioid Management|August 23, 2017
Clinical relevance of the pharmacokinetic characteristics of an abuse-deterrent, extended-release, injection-molded morphine tabletJeffrey M Dayno, Gwendolyn Niebler, John Lawler, et al.Journal of Opioid Management|January 9, 2018
Do abuse deterrent opioid formulations work?Richard C Dart, Janetta L Iwanicki, Nabarun Dasgupta, et al.Journal of Opioid Management|January 9, 2018
Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioidsChristopher J Miller, Richard C Dart, Nathaniel P Katz, et al.Journal of Opioid Management|January 9, 2018
Reality and responsibility revisited: Stakeholder accountability in the effort to develop safer opioidsSteven D Passik, Howard A Heit, Michael DeGeorgeJournal of Opioid Management|January 9, 2018
Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorderTheresa A Cassidy, Eileen Thorley, Ryan A Black, et al.Journal of Opioid Management|January 9, 2018
Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 TestingChristopher Altomare, Eric R Kinzler, August R Buchhalter, et al.Journal of Opioid Management|January 11, 2021
The impact of long-term opioid use on the risk and severity of COVID-19Rahul Shah, Yong-Fang Kuo, Jacques Baillargeon, et al.Journal of Opioid Management|January 11, 2021
Identifying sociodemographic profiles of veterans at risk for high-dose opioid prescribing using classification and regression treesJacob S Lipkin, Joshua M Thorpe, Walid F Gellad, et al.Journal of Opioid Management|January 11, 2021
Narcotic use in patients following a traumatic injuryPageof 100